Percutaneous BCG perfusion of the upper urinary tract for carcinoma in situ.
Studer
U E
UE
Department of Urology, University of Bern, Inselspital, Switzerland.
Casanova
G
G
Kraft
R
R
Zingg
E J
EJ
D000368:Aged; D000369:Aged, 80 and over; D001500:BCG Vaccine / Q000008:administration & dosage*; D002278:Carcinoma in Situ / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D006801:Humans; D007167:Immunotherapy; D007680:Kidney Neoplasms / Q000601:surgery; D009378:Neoplasms, Multiple Primary; D010477:Perfusion / Q000379:methods; D001749:Urinary Bladder Neoplasms / Q000601:surgery / Q000628:therapy*
D001500:BCG Vaccine